Bayer: Hypertension trials
The registry lists 33 Hypertension studies with Bayer as lead sponsor. 0 are open to participants now and 4 have results posted.
Phase 1 2Phase 2 3Phase 3 9Phase 4 6No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)TerminatedNCT02138825Phase 2Results posted
- Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential HypertensionCompletedNCT01788358Phase 3Results posted
- Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD StudyCompletedNCT00768560Phase 2Results posted
- Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With PrehypertensionCompletedNCT00420342Phase 2Results posted
- A Study to Learn About the Safety of BAY3283142 in People With Mild to Moderate High Blood PressureCompletedNCT06428825Phase 1
- A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple DosesCompletedNCT05491642Phase 1
- Effectiveness and Tolerability of Long-Acting Nifedipine Gastrointestinal Therapeutic System in Chronic Kidney Disease With Uncontrolled Hypertension Patients, a Prospective, Multicenter, Observational StudyCompletedNCT03194633
- A Cross-sectional Study for the Determination of the Prevalence of Non-valvular Atrial Fibrillation Among Patients Diagnosed With HypertensionCompletedNCT02585076
- Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.CompletedNCT02413515Phase 4
- Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan CilexetilWithdrawnNCT02047019Phase 3
- Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential HypertensionCompletedNCT01518855Phase 4
- Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life SettingCompletedNCT01392534
- Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney DiseaseCompletedNCT01363336
- High Dose BAYA1040 CR: a Long Term Extension StudyCompletedNCT01355367Phase 3
- High Dose BAYA1040_Nifedipine: a Long Term Combination StudyCompletedNCT01294215Phase 3
- High Dose BAYA1040_Nifedipine: a Dose-comparative StudyCompletedNCT01287260Phase 3
- Xirtam H Combination In the Treatment of Hypertension Evaluation Study.CompletedNCT01219556
- COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-i Treatment Due to couGH in SlovakiaCompletedNCT01217879
- COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in PolandCompletedNCT01211171
- Treatment of Hypertension With Adalat® in Combination With Other DrugsCompletedNCT01118286
- Survey to Assess Why People Are Not Responding to Treatment in HypertensionCompletedNCT01071681
- FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)CompletedNCT01071122Phase 4
- Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential HypertensionCompletedNCT00993109Phase 4
- Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR TreatmentCompletedNCT00932867
- Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®CompletedNCT00927537
- Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.CompletedNCT00750113Phase 4
- Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic PatientsWithdrawnNCT00713011Phase 3
- Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With HypertensionCompletedNCT00672113Phase 4
- Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or HyperlipidemiaCompletedNCT00668109Phase 3
- Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and HypertensionCompletedNCT00668005Phase 3
- The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial HypertensionCompletedNCT00471003
- Assessment of Compliance With Antihypertensive Telmisartan TherapyCompletedNCT00470886
- Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive WomenCompletedNCT00102141Phase 3